Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Blood Advances|May 12, 2026
Prognostic Value of Combined Baseline FDG PET/CT Radiomic Parameters in Primary Mediastinal B-Cell LymphomaPierre Decazes, Cedric Rossi, Pierre Sesques, et al.
Blood Advances|September 18, 2024
Identification of primary mediastinal B-cell lymphomas with higher clonal dominance and poorer outcome using 5'RACEVincent Camus, Mathieu Viennot, Pierre-Julien Viailly, et al.
Clinical and Experimental Medicine|August 11, 2022
Reduced peripheral blood dendritic cell and monocyte subsets in MDS patients with systemic inflammatory or dysimmune diseasesVincent Jachiet, Laure Ricard, Pierre Hirsch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 13, 2024
Long-Term Follow-Up of the Prospective Randomized AATT Study (Autologous or Allogeneic Transplantation in Patients With Peripheral T-Cell Lymphoma)Olivier Tournilhac, Bettina Altmann, Birte Friedrichs, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 11, 2026
High-Dose Methotrexate as CNS Prophylaxis in Ultra High-Risk Large B-Cell Lymphoma: An International Multicenter AnalysisMatthew R Wilson, Katharine L Lewis, Amy A Kirkwood, et al.
European Journal of Cancer (Oxford, England : 1990)|March 29, 2025
Primary mediastinal B-cell lymphoma (PMBCL): The LYSA pragmatic guidelinesLoïc Renaud, Marie Donzel, Justine Decroocq, et al.
American Journal of Hematology|December 10, 2019
Impact of MYD88<sup>L265P</sup> mutation status on histological transformation of Waldenström MacroglobulinemiaSaurabh Zanwar, Jithma P Abeykoon, Eric Durot, et al.
Blood Advances|April 14, 2026
Interim assessment by circulating tumor DNA in primary mediastinal large B-cell lymphoma: a multicenter LYSA studyVincent Camus, Daphné Krzisch, Alessio Bruscaggin, et al.
Pageof 6